<DOC>
	<DOCNO>NCT02854696</DOCNO>
	<brief_summary>The main goal perform cost-utility analysis compare islet cell transplantation versus best medical treatment ( define Sensor augment pump therapy ) patient brittle type1 diabetes .</brief_summary>
	<brief_title>Health Economic Analysis Islet Cell Transplantation Stabilization Severe Forms Type 1 Diabetes</brief_title>
	<detailed_description>The main goal perform cost-utility analysis compare islet cell transplantation versus best medical treatment ( define Sensor augment insulin pump therapy ) patient brittle type1 diabetes .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>Inclusion Criteria : Suffering diabetes since 5 year Patient brittle type 1 diabetes despite optimized insulin treatment educational training include . A patient consider experience brittle type 1 diabetes least two criterion present among : persistence severe hypoglycemia , occurrence ketoacidosis event without obvious etiology , diagnosis unaware hypoglycemic episode &lt; 3 mmol/l base CGM selfmonitoring blood glucose data , mean blood glucose standard deviation &gt; 50 % , MAGE index ( Mean amplitude glucose excursion ) &gt; 60 mg/dl , LBGI index ( low blood glucose index ) &gt; 5 , Clarke scoreâ‰¥4 HYPOSCORE &gt; 800 . Insulin need &lt; 0,85 U/kg/day HbA1c &lt; 12 % ; No residual insulin secretion ( plasmatic basal stimulate Cpeptide &lt; 0.3 ng/ml ) Social Security membership benefit Social Security Patients sign consent form Exclusion Criteria : Exclusion criterion related islet infusion : Hemostatic disorder , preexist liver disease ( PAL , GammaGT , ASATALAT &gt; 2N ) vesicular lithiasis . Exclusion criterion relate diabetic complication : Evolutive proliferative retinopathy , evolutive nephropathy ( Glomerular filtration rate &lt; 30 ml/min/1.73m2 and/or proteinuria &gt; 0.5g/day ) , evolutive cardiopathy obliterative arteriopathy trophic cutaneous lesion . Exclusion criterion related immunosuppressant use : Hemoglobin &lt; 110mg/dL woman &lt; 120 mg/dL men , leuconeutropenia , thrombopenia , systemic infection include chronic hepatitis B , C VIH , neoplasia disease hypertension &gt; 160/100 mmHg . Corticoid treatment ( except patient benefit kidney graft maintenance steroid therapy ) Presence antiHLA antibody direct donor Positive B T cell crossmatch</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Islet cell Transplantation</keyword>
	<keyword>cost-effectiveness analysis</keyword>
	<keyword>Cost-utility analysis</keyword>
	<keyword>Type 1 Diabetes</keyword>
</DOC>